What to Read Next
Necessity, as the saying goes, is the mother of invention. As the COVID-19 crisis spread during the first half of 2020, organizations innovated at a much faster pace than they normally could have. Emergency room teams in Michigan rigged ventilators by adding a second tube to double capacity and ventilate two patients at a time. Chinese scientists sequenced the new COVID-19 virus in a record three weeks. Multiple teams from Oxford, London, and Boston developed a potential vaccine and began testing it in less than two months. And the U.K.’s National Health Service built a 4,000-bed hospital in just four days.
Why is it that innovation seems more possible during a crisis? More important, how might organizations sustain similar levels of innovation once the crisis has passed? In our work with both public- and private-sector organizations, we have identified five interdependent conditions that characterize a crisis and boost innovation.
- A crisis provides a sudden and real sense of urgency.
- This urgency enables organizations to drop all other priorities and focus on a single challenge, reallocating resources as needed.
- With this singular focus and reallocated resources, it’s now everybody’s job to come together to solve the problem, bringing a new diversity of viewpoints and perspectives.
- This urgency and singular focus legitimizes what would otherwise constitute “waste,” allowing for more experimentation and learning.
- Because the crisis is only temporary, the organization can commit to a highly intense effort over a short period of time.
Research Updates From MIT SMR
Get weekly updates on how global companies are managing in a changing world.
Please enter a valid email address
Thank you for signing up
Leaders can replicate proxy crisis conditions as a way to generate more effective innovation in noncrisis times. However, that requires a deeper understanding of the issues at play in each of the five conditions.
1. A crisis provides a sudden and real sense of urgency. Proximity to a grave problem creates a critical sense of urgency, focusing attention and galvanizing action.
Read the Full ArticleAlready a subscriber? Sign in
1. H. Omer and N. Alon, “The Continuity Principle: A Unified Approach to Disaster and Trauma,” American Journal of Community Psychology 22, no. 2 (April 1994): 273-287.
2. A. Tversky and D. Kahneman, “Availability: A Heuristic for Judging Frequency and Probability,” Cognitive Psychology 5, no. 2 (September 1973): 207-232.
3. D. Kahneman and A. Tversky, “Prospect Theory: An Analysis of Decision Under Risk,” Econometrica 47, no. 2 (March 1979): 263-291; and A. Tversky and D. Kahneman, “The Framing of Decisions and the Psychology of Choice,” Science 211, no. 4481 (January 1981): 453-458.
4. Elsbeth Johnson has termed this the Drama Delusion, and it particularly affects leaders in larger and older companies. See E. Johnson, “The Four Delusions of Leadership,” Dialogue Review, May 15, 2020, https://dialoguereview.com.
5. “Virtual Health: Now You Can Get Medical Care From Your Home,” Hartford HealthCare, April 16, 2020.
6. N. El Hennawy, “COVID-19: Telehealth Businesses Set to Grow During Pandemic,” Zawya, June 9, 2020, www.zawya.com.
7. E. Johnson, “Step Up, Step Back: How to Really Deliver Strategic Change in Your Organization” (London: Bloomsbury Business, 2020).
8. L. Eisenstadt, “How Broad Institute Converted a Clinical Processing Lab Into a Large-Scale COVID-19 Testing Facility in a Matter of Days,” Broad Institute, March 27, 2020, www.broadinstitute.org.
9. R.L. Martin, “The Big Lie of Strategic Planning,” Harvard Business Review 92, no. 1-2 (January-February 2014): 78-84; and D. Sull, S. Turconi, C. Sull, et al., “Turning Strategy Into Results,” MIT Sloan Management Review 59, no. 3 (spring 2018): 9-20.
10. D. Rock, H. Grant, and J. Grey, “Diverse Teams Feel Less Comfortable — and That’s Why They Perform Better,” Harvard Business Review, Sept. 22, 2016, https://hbr.org.
11. P. Stokes, “Crossing Disciplines: A Constraint-Based Model of the Creative/Innovative Process,” The Journal of Product Innovation Management 31, no. 2 (October 2013): 247-258.
12. Johnson, “Step Up, Step Back.”
13. I.A. Hamilton, “Bill Gates Is Funding New Factories for Seven Potential Coronavirus Vaccines,” Business Insider, April 3, 2020, www.businessinsider.com.
14. “The Grand Challenge,” Defense Advanced Research Projects Agency, accessed Aug. 27, 2020, www.darpa.mil.
15. T. Amabile and S.J. Kramer, “The Power of Small Wins,” Harvard Business Review 89, no. 5 (May 2011): 70-80.